Skip to main content
Equibles

ENTERO · Entero Healthcare Solutions Limited

Use ENTERO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENTERO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,968.70 INR -2.30 (-0.12%) At close · Nov 13
Rebalance outlook locked
Market Cap
85.68B INR
Shares
43.52M
Volume · Nov 13 59.18K Avg daily vol (3M) 290.63K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close1,968.70 INR Open1,971.00 INR Day1,960.10–2,005.00 INR 52W close949.20–2,114.90 INR Avg vol 30d224K Last earningsNov 5, 2026 DataFeb 2024–Nov 2026

Latest documents

2026
Nov 5
Earnings call
Revenue rises 32.9%, management expects guidance beat

Entero Healthcare Solutions Limited reported Q2 revenue of INR2,087 crores, up 32.9%, and EBITDA growth of 78%; management expects to beat FY 2027 guidance of approximately 23% revenue growth, a 5% EBITDA margin and 50% EBITDA-to-operating-cash-flow conversion.

4 source passages
Entero Healthcare Solutions Limited Q2FY27 earnings call hosted by DAM Capital Advisors. Consolidated revenues grew by 32.9% to INR2,087 crores. Gross margin expanded 126 basis points year-on-year to 11.5%, and EBITDA margin expanded 135 basis points to 5.3%, and EBITDA grew by 78% year-on-year. We remain confident of sustaining the momentum in second half of the financial year and are in a comfortable position to deliver better than our stated FY 2027 guidance - which is consolidated revenue growth of approximately 23% (excluding any contribution from new acquisitions), alongside an EBITDA margin of 5% and EBITDA to operating cash flow conversion of 50%. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲36.9% 13.59B INR 254.38M INR '25 Q3 ▲29.5% 13.39B INR 256.86M INR '25 Q4 ▲28% 14.04B INR 277.99M INR '26 Q1 ▲20.8% 15.71B INR 316.01M INR '26 Q2 ▲25.6% 17.07B INR 276.33M INR '26 Q3 ▲42.6% 19.10B INR 280.09M INR '26 Q4 ▲38.2% 19.40B INR 381.62M INR '27 Q1 LATEST ▲32.9% 20.87B INR 455.43M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 949.20 INR Now 1,968.70 INR · 87% Range high 2,114.90 INR
vs 200-day avg +47% vs 50-day avg +14%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:ENTERO +3.6% +24.5% +45.4% +25.0% +91.8%

Exchange listing

Market
XNSE
Ticker
ENTERO
ISIN
INE010601016
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.enterohealthcare.com/
Investor relations
https://www.enterohealthcare.com/investor/financials/quarterly-financial-results.php

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-10 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-26 Audio Transcript
    “Entero Healthcare Solutions Limited Q4 FY26 Earnings Conference Call”
  • Earnings call · Q3 2026 2026-02-13 Audio Transcript
    Entero Healthcare Solutions Limited Q3FY26 Earnings Conference Call February 13, 2026